This Is the SpaceX Number No One Is Talking About -- and History Says It May Total $175 Billion

SpaceX is reportedly preparing a confidential IPO with an estimated $1.75 trillion valuation and $75 billion capital raise, which would make it the largest IPO in history. The article highlights reported 2025 profitability of about $8 billion on up to $16 billion in revenue, but cautions that mega-IPOs have historically averaged a 10% decline six months after debut. The piece is mostly commentary, but it could shape investor expectations around SpaceX and the broader 2026 IPO pipeline.

Analysis

The market is likely to treat a SpaceX listing as a de facto liquidity event for the entire private-tech complex, not just one issuer. If the deal is priced at extreme scarcity multiples, the first-order pop will probably come from passive benchmark inclusion and retail momentum, but the second-order effect is a re-rating of late-stage private rounds across adjacent winners and losers: profitable, capital-intensive infrastructure names should see tighter private financing spreads, while unprofitable AI platforms may face a harsher “prove it post-IPO” bar. That is a headwind for the late-stage venture ecosystem because the public market will be asked to absorb growth at a time when rates are still high enough to punish long-duration cash flows.

The historical analog is more useful for timing than for valuation. Mega-IPOs tend to underperform over the first 3-6 months because anchor demand is crowded, insider supply eventually arrives, and underwriters over-optimize for deal success rather than secondary market elasticity. A SpaceX float would likely create a temporary valuation gravity well for all “Musk premium” assets: TSLA could get an initial sympathy bid, but the bigger risk is that investors rotate from public Tesla into the new story, especially if SpaceX is presented as the cleaner pure-play on autonomy-adjacent AI, broadband, and launch infrastructure.

The clearest relative winners are capital-light index owners and payments/market-structure beneficiaries rather than the headline stock itself. V is a subtle beneficiary if the IPO widens retail participation and increases transaction volumes around new listings, while NVDA/INTC get only indirect support from an AI-capex halo, not from any immediate spend shift. META, GM, and UPS look like valuation foils: if the market starts paying peak multiples for private “platform” assets, it may compress the multiple tolerance for legacy ad, auto, and logistics names with slower growth and less narrative optionality.

Contrarian risk: the market may already be overpricing the scarcity value before the prospectus exists. If the roadshow reveals lower growth in Starlink or a higher-than-expected capital intensity profile, the stock could re-rate like a mature infrastructure business rather than a moonshot, which would punish the halo trade more than the actual IPO. The bigger tradeable event may be the lock-up expiry and first-quarter post-listing guidance, not the debut itself.

Key Decisions for Investors

• Fade the first-week enthusiasm: short a basket of high-beta private-growth proxies against long V or a market-neutral mega-cap liquidity basket for a 1-3 month window; thesis is that deal-day euphoria fades faster than structural demand.
• Long TSLA / short META into the IPO marketing cycle for 4-8 weeks: TSLA should retain the stronger scarcity premium if investors view Musk exposure as the cleaner public analogue, while META is more vulnerable if the market re-prices narrative-heavy growth.
• Avoid chasing the IPO in the first 30 trading days; wait for the first secondary offering or lock-up overhang, then consider a tactical long only if post-listing volatility compresses below the implied range.
• Pair long NVDA vs short INTC only on any AI halo overreaction; use it as a 3-6 month relative-value expression because SpaceX excitement is likely to benefit AI sentiment broadly, but only NVDA has the earnings power to convert that into multiple durability.
• If SpaceX lists above 20x forward sales equivalent, buy put spreads 2-4 months out on the first post-IPO dip; risk/reward improves once insider supply and normalization mechanics begin to matter.